AstraZeneca knocked confidence in the UK stockmarket by the end of Wednesday's trading after the Dut...
AstraZeneca knocked confidence in the UK stockmarket by the end of Wednesday's trading after the Dutch antitrust regulator said the pharmaceutical firm has violated Dutch competition rules, alongside news of more accounting irregularities in the US. The FTSE 100 retreated for a third day and dropped another 2.1% to 4448.1 points as the usual suspects - AstraZeneca, GlaxoSmithKline, Vodafone and Shell Transport & Trading - accounted for about half the slide. AstraZeneca lost 186p or 7% to £24.60 after the Dutch antitrust regulator said the firm violated Dutch competition rules by s...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes